| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A conformational transition of the D′D3 domain primes von Willebrand factor for multimerization
|
Gruber, Sophia
|
|
|
6 |
17 |
p. 5198-5209
|
article
|
| 2 |
American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis for patients with COVID-19: March 2022 update on the use of anticoagulation in critically ill patients
|
Cuker, Adam
|
|
|
6 |
17 |
p. 4975-4982
|
article
|
| 3 |
American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: January 2022 update on the use of therapeutic-intensity anticoagulation in acutely ill patients
|
Cuker, Adam
|
|
|
6 |
17 |
p. 4915-4923
|
article
|
| 4 |
A starting point for the phenotypic classification of pulmonary chronic graft-versus-host disease
|
Pang, Yifan
|
|
|
6 |
17 |
p. 4987-4988
|
article
|
| 5 |
BMX kinase mediates gilteritinib resistance in FLT3-mutated AML through microenvironmental factors
|
Buelow, Daelynn R.
|
|
|
6 |
17 |
p. 5049-5060
|
article
|
| 6 |
Cardiac events in patients with acute myeloid leukemia treated with venetoclax combined with hypomethylating agents
|
Johnson, Isla M.
|
|
|
6 |
17 |
p. 5227-5231
|
article
|
| 7 |
Causes of death in low-grade B-cell lymphomas in the rituximab era: a prospective cohort study
|
Tun, Aung M.
|
|
|
6 |
17 |
p. 5210-5221
|
article
|
| 8 |
Clinical characteristics and outcomes of IgD myeloma: experience across UK national trials
|
Agbuduwe, Charles
|
|
|
6 |
17 |
p. 5113-5123
|
article
|
| 9 |
Combined BCL2 and BTK inhibition in CLL demonstrates efficacy after monotherapy with both classes
|
Hyak, Jonathan M.
|
|
|
6 |
17 |
p. 5124-5127
|
article
|
| 10 |
Commentary on the 2021 ASH Guidelines on use of anticoagulation in patients with COVID-19 being discharged from the hospital
|
Spyropoulos, Alex C.
|
|
|
6 |
17 |
p. 5045-5048
|
article
|
| 11 |
CPT2 K79 acetylation regulates platelet life span
|
Fan, Xuemei
|
|
|
6 |
17 |
p. 4924-4935
|
article
|
| 12 |
D-dimer and risk for thrombosis in adults with newly diagnosed acute lymphoblastic leukemia
|
Anderson, Daniela R.
|
|
|
6 |
17 |
p. 5146-5151
|
article
|
| 13 |
Defective RAB31-mediated megakaryocytic early endosomal trafficking of VWF, EGFR, and M6PR in RUNX1 deficiency
|
Jalagadugula, Gauthami
|
|
|
6 |
17 |
p. 5100-5112
|
article
|
| 14 |
Direct oral anticoagulants in sickle cell disease: a systematic review and meta-analysis
|
Rozi, Waail
|
|
|
6 |
17 |
p. 5061-5066
|
article
|
| 15 |
Editorial Board
|
|
|
|
6 |
17 |
p. i
|
article
|
| 16 |
Efflux capacity and aldehyde dehydrogenase both contribute to CD8+ T-cell resistance to posttransplant cyclophosphamide
|
Patterson, Michael T.
|
|
|
6 |
17 |
p. 4994-5008
|
article
|
| 17 |
Genetic characterization and drug sensitivity study of newly derived HGBL double/triple-hit lymphoma cell lines
|
Zhang, Jibin
|
|
|
6 |
17 |
p. 5067-5071
|
article
|
| 18 |
Graft-versus-host disease may cause pulmonary restriction, but not all restriction is graft-versus-host disease
|
Sheshadri, Ajay
|
|
|
6 |
17 |
p. 4984-4986
|
article
|
| 19 |
Hematologist encounters among Medicaid patients who have sickle cell disease
|
Horiuchi, Sophia S.
|
|
|
6 |
17 |
p. 5128-5131
|
article
|
| 20 |
Impaired microtubule dynamics contribute to microthrombocytopenia in RhoB-deficient mice
|
Englert, Maximilian
|
|
|
6 |
17 |
p. 5184-5197
|
article
|
| 21 |
Invariant NKT cells dictate antitumor immunity elicited by a bispecific antibody cotargeting CD3 and BCMA
|
Casey, Mika
|
|
|
6 |
17 |
p. 5165-5170
|
article
|
| 22 |
In vivo genome-wide CRISPR screening in murine acute myeloid leukemia uncovers microenvironmental dependencies
|
Mercier, Francois E.
|
|
|
6 |
17 |
p. 5072-5084
|
article
|
| 23 |
Linked-read whole-genome sequencing resolves common and private structural variants in multiple myeloma
|
Peña-Pérez, Lucía
|
|
|
6 |
17 |
p. 5009-5023
|
article
|
| 24 |
Lower-leg injury and knee arthroscopy have distinct effects on coagulation
|
Touw, Carolina E.
|
|
|
6 |
17 |
p. 5232-5243
|
article
|
| 25 |
Low rate of subsequent malignant neoplasms after CD19 CAR T-cell therapy
|
Hsieh, Emily M.
|
|
|
6 |
17 |
p. 5222-5226
|
article
|
| 26 |
NK cells CD56bright and CD56dim subset cytokine loss and exhaustion is associated with impaired survival in myeloma
|
Seymour, Frances
|
|
|
6 |
17 |
p. 5152-5159
|
article
|
| 27 |
Noncanonical Sonic Hedgehog signaling amplifies platelet reactivity and thrombogenicity
|
Tiwari, Arundhati
|
|
|
6 |
17 |
p. 5024-5040
|
article
|
| 28 |
Outcomes of allogeneic hematopoietic cell transplantation in adults with fusions associated with Ph-like ALL
|
Aldoss, Ibrahim
|
|
|
6 |
17 |
p. 4936-4948
|
article
|
| 29 |
Pevonedistat plus azacitidine vs azacitidine alone in higher-risk MDS/chronic myelomonocytic leukemia or low-blast-percentage AML
|
Adès, Lionel
|
|
|
6 |
17 |
p. 5132-5145
|
article
|
| 30 |
Platelet-monocyte interaction amplifies thromboinflammation through tissue factor signaling in COVID-19
|
Hottz, Eugenio D.
|
|
|
6 |
17 |
p. 5085-5099
|
article
|
| 31 |
Quality of life, psychological distress, and prognostic perceptions in caregivers of patients with multiple myeloma
|
O'Donnell, Elizabeth K.
|
|
|
6 |
17 |
p. 4967-4974
|
article
|
| 32 |
Real-world study of children and young adults with myeloproliferative neoplasms: identifying risks and unmet needs
|
Sobas, Marta
|
|
|
6 |
17 |
p. 5171-5183
|
article
|
| 33 |
Src-related thrombocytopenia: a fine line between a megakaryocyte dysfunction and an immune-mediated disease
|
Palma-Barqueros, Verónica
|
|
|
6 |
17 |
p. 5244-5255
|
article
|
| 34 |
Tam CS, Dimopoulos M, Garcia-Sanz R, et al. Pooled safety analysis of zanubrutinib monotherapy in patients with B-cell malignancies. Blood Adv. 2022;6(4):1296-1308.
|
|
|
|
6 |
17 |
p. 4983
|
article
|
| 35 |
The dosing of ibrutinib and related Bruton's tyrosine kinase inhibitors: eliminating the use of brute force
|
Ratain, Mark J.
|
|
|
6 |
17 |
p. 5041-5044
|
article
|
| 36 |
Third-party CMV- and EBV-specific T-cells for first viral reactivation after allogeneic stem cell transplant
|
Jiang, Wei
|
|
|
6 |
17 |
p. 4949-4966
|
article
|
| 37 |
Transplant outcomes after CPX-351 vs 7 + 3 in older adults with newly diagnosed high-risk and/or secondary AML
|
Uy, Geoffrey L.
|
|
|
6 |
17 |
p. 4989-4993
|
article
|
| 38 |
Unified gene expression signature of novel NPM1 exon 5 mutations in acute myeloid leukemia
|
Lisi, Véronique
|
|
|
6 |
17 |
p. 5160-5164
|
article
|
Journal description